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A 2-week-old girl was transferred to PICU following cardiopulmonary resuscitation locally.
Echocardiogram showed severe aortic coarctation and closed ductus arteriosus. She was
commenced on infusion of prostaglandin E1 at 10 ng/kg/min increased to 50 ng/kg/min as
the ductus arteriosus remained closed. She was referred to cardiac centre for further
management. Echocardiogram conﬁrmed juxta-ductal aortic coarctation with reduced
peak systolic gradient, no diastolic blood ﬂow continuation on Doppler assessment of
blood ﬂow in descending aorta, and a very small ductus arteriosus with bidirectional
shunt. Serum lactate gradually reduced to less than 1 mmol/L from 11 mmol/L recorded
before transfer. The use of high dose prostaglandin E is warranted in critically ill neonates
with aortic coarctation and closed arterial duct unresponsive to conventional doses.
Beneﬁcial effect of high doses of prostaglandin E goes in this indication beyond primary
arterial ductal reopening.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Cardiovascular malformation still remains the commonest type
of congenital malformation and most importantly accounts for
6–10% of all infant deaths [1]. Recently, with the trend towards
early postnatal discharge cardiovascular malformations with
duct dependent systemic or pulmonary circulation can easily be
missed. Hence it is important that health care professionals
treating critically ill neonates are aware of and trained in
management of these neonates and infants. The standard
treatment of a collapsed neonate with suspected congenital heart
disease includes ﬂuid management, mechanical ventilation,ch Society of Cardiology.
ital, Sydney Street, Lond
.uk, zslavik@hotmail.comantibiotic administration to cover sepsis, inotropic support
if necessary, and infusion of prostaglandin E with a view to
maintain patency of ductus arteriosus until a conﬁrmative
cardiac diagnosis is reached. However, in the current era, it is
not uncommon for neonatologists and/or paediatric intensi-
vists with special interest in paediatric cardiology to diagnose
congenital heart disease with duct dependent systemic or
pulmonary circulation [2]. Echocardiographic ﬁnding of a closed
ductus arteriosus in the setting of suspected aortic coarctation
in a critically ill neonate prior to transfer may inﬂuence the
decision of a referring team or a transport team towards
discontinuing or not escalating prostaglandin E infusion.Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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We report case of a 2-week-old neonate with critical coarcta-
tion of aorta and closed arterial duct at referral, who
responded well to a large dose of prostaglandin E1 with
minimal re-opening of the ductus arteriosus.
The patient was a 15 day old girl transferred to our
institution from another paediatric intensive care unit. She
was born at term, without any risk factors for sepsis and the
Apgar scores were 9 and 10 at 1 and 5 min, respectively.
Mother was a primigravida and the antenatal scans were
reported as normal. She was discharged home on the day of
delivery after a normal postnatal check. She had been feeding
well at home and gaining weight. On day 14 of her life,
she presented to district general hospital with history of
high pitched cry and episodes of pallor around lips. Her
clinical examination was unremarkable apart from cold
extremities and prolonged capillary reﬁll time. No murmur
was audible. While in the Children's Emergency Depart-
ment, she became cyanosed, apnoeic and bradycardic. She
received bag and mask ventilation and chest compressions
and was subsequently intubated, ventilated and transferred
to the local paediatric intensive care unit for further
management.
On the intensive care unit, her initial examination
revealed weak left radial and femoral pulses. She was started
on broad spectrum antibiotics for possible sepsis. The echo-
cardiogram showed severe juxta-ductal coarctation of
aorta with a peak systolic Doppler derived gradient of
36 mmHg with diastolic continuation of blood ﬂow. The
ductus arteriosus was not patent. She also had small peri-
membranous ventricular septal defect and moderately
impaired left ventricular systolic function. She was com-
menced on intravenous infusion of prostaglandin E1 at
10 ng/kg/min and the dose was increased up to 50 ng/k/min
as the ductus arteriosus remained closed echocardiographi-
cally. She was referred to our hospital for further manage-
ment and transferred by the paediatric retrieval team
uneventfully.
On arrival, she was clinically stable. Her right arm and left
leg systolic blood pressures were 70 mmHg and 53 mmHg,
respectively. Her femoral pulses were very weak. She had
normal cardiac impulse with normal ﬁrst and prominent
pulmonary component of second heart sound. The repeat
echocardiogram showed patent foramen ovale with left
to right shunt, perimembranous ventricular septal defect,
no aortic stenosis or regurgitation, mildly impaired
left ventricular systolic function, left-sided aortic arch with
discrete juxta-ductal coarctation, and very small patent
ductus arteriosus with bidirectional shunt. Interestingly, the
Doppler trace was now suggestive of peak systolic pressure
drop across the coarcted segment of 18 mmHg with no
obvious diastolic blood ﬂow continuation. Over the next few
hours, the serum lactate has reduced to values below
1 mmol/L (highest lactate level recorded prior to transfer
was 11 mmol/L.) She was operated on the following day
(day 16 of life) with good surgical result. The postoperative
period was uneventful. She recovered well and was
discharged home.3. Discussion
Despite recent developments in antenatal and postnatal
screening the diagnosis of critical aortic coarctation is often
delayed until the patient develops congestive heart failure,
usually in the ﬁrst 2–3 weeks of life [1]. The initial manage-
ment of a neonate with critical aortic coarctation includes
treatment with diuretics or ﬂuid resuscitation with or with-
out inotropes and with prostaglandin E infusion to maintain
patency of ductus arteriosus.
The aortic coarctation is thought to develop from arterial
ductal tissue extending into the aortic lumen and from
hypoplasia of the arch secondary to its underdevelopment
by reduced antegrade blood ﬂow prenatally [3]. In majority of
cases the ductal tissue can more or less completely encircle
the adjacent aortic lumen. In a histopathological study of 45
cases with discrete aortic coarctation, ductal tissue formed
the inner part of the aortic ridge for more than half of its total
circumference [4]. Hence, constriction of the ductus arterio-
sus will be accompanied by further obstruction to aortic
lumen (coarctation) postnatally.
Prostaglandin E1 is a potent dilator of arterial ductal tissue
and therefore useful in the early treatment of aortic coarcta-
tion. Its beneﬁcial effect can be ascribed to the opening of
ductus arteriosus allowing for right-to-left shunting and
improved systemic blood ﬂow supplying lower part of the
body. Moreover, relaxation of the ductal tissue in aortic wall
can widen the diameter of coarctated segment of the aorta
without necessarily reopening the ductus arteriosus itself.
The usual recommended starting dose range of prosta-
glandin E1 for intravenous infusion is 5–10 ng/kg/min to
avoid sudden onset of apnoea and/or systemic hypotension.
In our case, the echocardiogram done prior to referral showed
that the arterial duct had closed and aortic coarctation was
present. No change in echocardiographic ﬁndings was pre-
sent while prostaglandin E1 infusion dose remained at
10 ng/kg/min. This dose was increased to 20 and subsequently
to 50 ng/kg/min. The echocardiogram performed in our unit
then showed a very small arterial duct with bidirectional
shunt that was insufﬁcient on its own to maintain forward
ﬂow through the descending aorta. Interestingly, the peak
systolic velocity derived gradient had reduced to 18mmHg
from 36mmHg before transfer and no obvious diastolic blood
ﬂow continuation was present on Doppler interrogation of the
descending aorta. There had been concomitant improvement
in systemic perfusion evidenced by marked reduction
in serum lactate levels. (Figs. 1 and 2)
Our case follows similar report published previously [5].
We with others believe that the use of high dose prostaglan-
din E is warranted in critically ill neonates and young infants
with aortic coarctation and arterial duct unresponsive to
conventional doses. Beneﬁcial effect of these higher doses
of prostaglandin E goes clearly beyond primary arterial ductal
reopening. In our opinion this effect outweighs small risk of
usually transient apnoea and the potential need for artiﬁcial
ventilation.
With the emergence of neonatal and paediatric acute
transport teams and advancing training of neonatologists,
paediatricians, and transport physicians in echocardiography
Fig. 1 – (a) (Prior to starting PGE1): Continuous wave (CW) Doppler trace showing peak systolic velocity across coarctation site of
3 m/s (equivalent to pressure drop of 36 mmHg) with obvious diastolic blood ﬂow continuation. (b) (Prior to starting PGE1):
Showing site of aortic coarctation segment and closed arterial duct. Note turbulence at the coarctation site.
Fig. 2 – (a) (Post PGE1 infusion): Continuous wave (CW) Doppler trace showing reduced peak systolic velocity and gradient across
coarctation site (just over 2 m/s equivalent to pressure drop of 18 mmHg) without diastolic blood ﬂow continuation. (b) (Post
PGE1 infusion): Showing widening of aortic coarctation segment and a small arterial duct. Note reduced turbulence at the
coarctation site compared to the initial echocardiographic picture (1a).
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 6 0 – e 4 6 2e462diagnosis of aortic coarctation is likely to be made more
frequently before transfer to paediatric cardiac centres. Lack
of arterial ductal reopening with prostaglandin E administra-
tion on echocardiogram must not lead to interruption in
prostaglandin administration. Increased dose of prostaglan-
din E should be considered while respiratory effort and
airway patency is carefully monitored. This important step
in early treatment of critically ill neonates and young infants
with aortic coarctation delivered by referring as well as
transferring teams is essential for improvement of outcome
in this, still potentially lethal congenital heart defect.
r e f e r e n c e s
[1] A. de-Wahl Granelli, M. Wennergren, K. Sandberg, et al.,
Impact of pulse oximetry screening on the detection of ductdependent congenital heart disease: a Swedish prospective
screening study in 39821 newborns, Journal of Pediatrics 155
(1) (2009) 147–148.
[2] S. Moss, N.V. Subhedar, Echocardiography on the neonatal
unit, Archives of Disease in Childhood 87 (2002) 171.
[3] A.M. Rudolph, M.A. Heymann, U. Spitznas, Hemodynamic
considerations in the development of narrowing of the aorta,
American Journal of Cardiology 30 (1972) 514–525.
[4] N.J. Elzenga, A.C. Gittenberger-de Groot, Localised coarctation
of the aorta, an age dependent spectrum, British Heart Journal
49 (1983) 317–323.
[5] L. Liberman, W.M. Gersony, P.A. Flynn, et al., Effectiveness of
prostaglandin E1 in relieving obstruction in coarctation of the
aorta without opening the ductus arteriosus, Pediatrics
Cardiology 25 (1) (2004) 49–52.
